Image credit- shutterstock.com
The Board of Directors of Morepen Laboratories has approved the investment proposed by Corinth Group, a global private investment Group, headquartered in Switzerland, to the extent of $32.50 million in the parent company, Morepen Laboratories Limited, out of a total $100 million (Rs 750 crores approx) investment in the promoter group, subject to approval of the shareholders and other regulatory bodies.
Following shareholder and regulatory approval, Corinth would be allotted 58.50 million new Equity shares on preferential basis. This shareholding would equate to 9.41% equity stake in the Company on a fully expanded capital base. The balance $67.50 million would be in the promoter group companies.
The funds would be used in: